ACVR1 and fibrodysplasia ossificans progressiva: Given that the anti-ACVR1 antibodies block interaction of ACVR1 with its ligands, we considered it unlikely that the anti-ACVR1 antibody–induced signaling involves activin A, the obligate ligand for HO in FOP.